[Analysis of F.IX-inhibitor bypassing activity contained in a commercial prothrombin complex concentrate (Proplex)].
D001779:Blood Coagulation Factors / Q000032:analysis / Q000627:therapeutic use*; D002648:Child; D005164:Factor IX / Q000037:antagonists & inhibitors*; D002836:Hemophilia B / Q000188:drug therapy*; D006801:Humans
D001779:Blood Coagulation Factors; C025667:prothrombin complex concentrates; D005164:Factor IX